Suchergebnisse
Suchergebnisse:
27. Juni 2024 · a16z managing partner Scott Kupor and Sequoia partner Alfred Lin will join the board of directors of Formation Bio. Established in 2016 as TrialSpark, Formation Bio uses technology and AI to streamline drug development.
1. Juli 2024 · "We are in the early stages of AI driving significant efficiencies in pharma and biotech, and Formation Bio is well-positioned to lead this transformation," said Alfred Lin, Partner at Sequoia. "Ben and his team bring a unique mix of tech, pharma, and AI expertise, along with a track record in licensing high-quality drugs and ...
27. Juni 2024 · As part of this financing round, Scott Kupor, Managing Partner at a16z, and Alfred Lin, Partner at Sequoia, will join Formation Bio's Board of Directors. Formation Bio Use of Funds. The company plans to allocate the new capital towards two primary objectives: acquiring and in-licensing candidate drugs and expanding its AI capabilities.
26. Juni 2024 · As part of the financing, Scott Kupor, Managing Partner at a16z and Alfred Lin, Partner at Sequoia will join Formation Bio’s Board of Directors alongside existing board director Michael Moritz,...
27. Juni 2024 · Scott Kupor, managing partner at a16z, and Alfred Lin, partner at Sequoia, will join the board of directors at the firm, which leverages advances in artificial intelligence to enhance drug development efficiency.
26. Juni 2024 · As part of the financing, Scott Kupor, Managing Partner at a16z and Alfred Lin, Partner at Sequoia will join Formation Bio's Board of Directors alongside existing board director Michael Moritz, Sr. Advisor to Sequoia Heritage and board observer Kareem Zaki, Partner at Thrive Capital.
27. Juni 2024 · Alfred Lin has an estimated net worth of $4.23 Billion. This is based on reported shares across multiple companies, which include DoorDash, Inc., and Airbnb, Inc..
